ASPG and acute lymphoblastic leukemia: The multivariate analysis of EFS time showed that in addition to ALL‐BFM‐IC risk groups, the number of asparaginase doses (<10 doses) was also a variable to be considered in a parsimonious predictive model of risk factors.